Replies to post #480582 on Anavex Life Sciences Corp (AVXL)

[Hosai]

I wouldn't go that far but it does sound a little more broad than Donnanemabs 'indication summary' does it not? Perhaps should not be surprising considering the brain preservation findings - opposite to Donnanemab which shrinks the brain further.